Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis

Cancer

Volumn 118, Issue 23, 2012, Pages 5800-5810

  Kamarajan, Pachiyappan ^a   Alhazzazi, Turki Y ^a   Danciu, Theodora ^a   D'Silva, Nisha J ^a,b   Verdin, Eric ^c   Kapila, Yvonne L ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anoikis resistance; oral squamous cell carcinoma; orasphere; receptor interacting protein; sirtuin 3; tumorigenesis

Indexed keywords

BETA ACTIN; RECEPTOR INTERACTING PROTEIN; SIRTUIN 3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL AGGREGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOIMMUNOPRECIPITATION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; UPREGULATION;

ADULT; AGED; ANOIKIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIRTUIN 3;

EID: 84869500842     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27655     Document Type: Article

References (46)

1. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell. 2000; 100: 57-70. (Pubitemid 30046295)
2. Freedman VH, Shin SI,. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 1974; 3: 355-359.
3. Shin SI, Freedman VH, Risser R, Pollack R,. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci U S A. 1975; 72: 4435-4439.
4. Kantak SS, Kramer RH,. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem. 1998; 273: 16953-16961. (Pubitemid 28311727)
5. Grimshaw MJ, Cooper L, Papazisis K, et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells [serial online]. Breast Cancer Res. 2008; 10: R52.
6. Swan EA, Jasser SA, Holsinger FC, Doan D, Bucana C, Myers JN,. Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer. Oral Oncol. 2003; 39: 648-655. (Pubitemid 36930111)
7. Kupferman ME, Patel V, Sriuranpong V, et al. Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Oral Oncol. 2007; 43: 440-454. (Pubitemid 46561430)
8. Bunek J, Kamarajan P, Kapila Y,. Anoikis mediators in oral squamous cell carcinoma. Oral Dis. 2010; 17: 355-361.
9. Bsoul SA, Huber MA, Terezhalmy GT,. Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. J Contemp Dent Pract. 2005; 6: 1-16. (Pubitemid 41810916)
10. Kamarajan P, Bunek J, Lin Y, Nunez G, Kapila YL,. Receptor-interacting protein shuttles between cell death and survival signaling pathways. Mol Biol Cell. 2010; 21: 481-488.
11. Michan S, Sinclair D,. Sirtuins in mammals: insights into their biological function. Biochem J. 2007; 404: 1-13. (Pubitemid 46788079)
12. Verdin E, Hirschey MD, Finley LW, Haigis MC,. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci. 2010; 35: 669-675.
13. Huang JY, Hirschey MD, Shimazu T, Ho L, Verdin E,. Mitochondrial sirtuins. Biochim Biophys Acta. 2010; 1804: 1645-1651.
14. Alhazzazi TY, Kamarajan P, Joo N, et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 2011; 117: 1670-1678.
15. Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL,. SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta. 2011; 1816: 80-88.
16. Henson B, Li F, Coatney DD, et al. An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. J Oral Pathol Med. 2007; 36: 363-370. (Pubitemid 46889879)
17. Wolter KG, Wang SJ, Henson BS, et al. (-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia. 2006; 8: 163-172. (Pubitemid 43671231)
18. Cao Y, Fu YL, Yu M, et al. Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiation-induced oxidative stress. Free Radic Biol Med. 2009; 47: 1057-1066.
19. Sakamoto S, McCann RO, Dhir R, Kyprianou N,. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res. 2010; 70: 1885-1895.
20. Sakuma Y, Takeuchi T, Nakamura Y, et al. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src. J Pathol. 2010; 220: 574-585.
21. Iwanicki MP, Davidowitz RA, Ng MR, et al. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. 2011; 1: 144-157.
22. Stanger BZ, Leder P, Lee TH, Kim E, Seed B,. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 1995; 81: 513-523.
23. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P,. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 1998; 8: 297-303. (Pubitemid 28188890)
24. Temkin V, Huang Q, Liu H, Osada H, Pope RM,. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol. 2006; 26: 2215-2225. (Pubitemid 43346922)
25. Kasof GM, Prosser JC, Liu D, Lorenzi MV, Gomes BC,. The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria. FEBS Lett. 2000; 473: 285-291. (Pubitemid 30249141)
26. Bao J, Lu Z, Joseph JJ, et al. Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms. J Cell Biochem. 2010; 110: 238-247.
27. Cooper HM, Huang JY, Verdin E, Spelbrink JN,. A new splice variant of the mouse SIRT3 gene encodes the mitochondrial precursor protein [serial online]. PloS One. 2009; 4: e4986.
28. Cooper HM, Spelbrink JN,. The human SIRT3 protein deacetylase is exclusively mitochondrial. Biochem J. 2008; 411: 279-285. (Pubitemid 351580180)
29. Jin L, Galonek H, Israelian K, et al. Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3. Protein Sci. 2009; 18: 514-525.
30. Lombard DB, Alt FW, Cheng HL, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 2007; 27: 8807-8814.
31. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I,. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell. 2005; 16: 4623-4635. (Pubitemid 41416446)
32. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP,. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A. 2002; 99: 13653-13658. (Pubitemid 35215436)
33. Schwer B, North BJ, Frye RA, Ott M, Verdin E,. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol. 2002; 158: 647-657. (Pubitemid 34920104)
34. Shi T, Wang F, Stieren E, Tong Q,. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem. 2005; 280: 13560-13567. (Pubitemid 40517248)
35. Hafner AV, Dai J, Gomes AP, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY). 2010; 2: 914-923.
36. Shen HM, Lin Y, Choksi S, et al. Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol. 2004; 24: 5914-5922. (Pubitemid 38787975)
37. Lin Y, Choksi S, Shen HM, et al. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem. 2004; 279: 10822-10828. (Pubitemid 38372695)
38. Ahn BH, Kim HS, Song S, et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A. 2008; 105: 14447-14452.
39. Kong X, Wang R, Xue Y, et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis [serial online]. PloS One. 2010; 5: e11707.
40. Ashraf N, Zino S, Macintyre A, et al. Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer. 2006; 95: 1056-1061. (Pubitemid 44606833)
41. Li S, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ,. p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase [serial online]. PloS One. 2010; 5: e10486.
42. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP,. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest. 2009; 119: 2758-2771.
43. Yang H, Yang T, Baur JA, et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell. 2007; 130: 1095-1107. (Pubitemid 47410271)
44. Allison SJ, Milner J,. SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle. 2007; 6: 2669-2677. (Pubitemid 350224051)
45. Kim HS, Patel K, Muldoon-Jacobs K, et al. SIRT3 is a mitochondria- localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010; 17: 41-52.
46. Marfe G, Tafani M, Indelicato M, et al. Kaempferol induces apoptosis in 2 different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction. J Cell Biochem. 2009; 106: 643-650.